One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART StudyCamilla Muccini, Antonella Castagna, Caterina Candela et al.|Open Forum Infectious Diseases|2024Cited by 20
Risk of virological failure after drug burden reduction in people with 4-class drug-resistant HIV on virological suppression: A retrospective cohort analysis of data from the PRESTIGIO RegistryTommaso Clemente, Vincenzo Spagnuolo, Sara Diotallevi et al.|International Journal of Antimicrobial Agents|2024Cited by 3
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life settingRebecka Papaioannu Borjesson, Vincenzo Spagnuolo, Tommaso Clemente et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 2
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registryTommaso Clemente, Flavia Balena, Sara Diotallevi et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 2
Prevalence of Sexually Transmitted Infections Among Cisgender Women Coming to a Walk-In CenterGaia Catalano, Silvia Nozza, Tommaso Clemente et al.|Viruses|2025Cited by 1